Back to search

Article

Intratumoral viable biological agent as a Multi-Mechanism Therapeutic Strategy for Pancreatic Adenocarcinoma

2026-02-04

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Pancreatic ductal adenocarcinoma (PDAC) exhibits five-year survival rates below 10% with profound therapeutic resistance mediated by stromal barriers and immunosuppression [1,2]. Recent evidence suggests intratumoral mycobiome alterations may influence disease progression [17,18]. <bold>Methods:</bold> We performed comprehensive network pharmacology analysi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1a2b897-c2ce-58b4-a65c-15deb53b6bce
DOI
10.21203/rs.3.rs-8768147/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intratumoral viable biological agent as a Multi-Mechanism Therapeutic Strategy for Pancreatic AdenocarcinomaDOI 10.21203/rs.3.rs-8768147/v1
Select a neighboring publication to make it the new centre.